NAMS
NewAmsterdam Pharma Company N.V. · Healthcare
Chief Scientific Officer Johannes Jacob Pieter Kastelein sold $4.1M of NewAmsterdam Pharma Company N.V.
Sold$4,095,234
$21.50Price
190,476Shares
−100%Stake
What NAMS did after the filing
- The stock from Wed, Mar 27 close, $22.70
- −3.7%
- S&P 500, same days
- −0.6%
Measured over 30 trading days, to the May 9 close.
Traded Tue, Mar 26. Filed Wed, Mar 27, 12:30 PM ET, during the session. Returns use the Mar 27 close and the May 9 close. Not investment advice.